Compugen (CGEN) Treasury Shares (2024 - 2025)
Compugen (CGEN) reported Treasury Shares of $567400.0 for Q4 2025, up 78.79% on a YoY basis from $317350.0 in Q4 2024, and up 78.79% sequentially from $317350.0 in Q4 2024.
Compugen (CGEN) Treasury Shares (2024 - 2025) Analysis & Trends
Compugen (CGEN) has 2 years of Treasury Shares data on file, last reported at $567400.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 78.79% year-over-year to $567400.0; the trailing twelve-month figure through Dec 2025 stood at $567400.0 (up 78.79% YoY), and the FY2025 full-year result was $567400.0, up 78.79% from the prior year.
- Treasury Shares improved to $567400.0 in Q4 2025, from $317350.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $567400.0 in Q4 2025 to a low of $317350.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2024 | 317,350.00 |
| Dec 31, 2024 | 317,350.00 |